glp 1 agonist therapy GLP-1 Receptor Agonists: The New Wave in Diabetes Management Clinical Focus on GLP-1 Agonists

The reasoning is compelling

Macular Edema: Poorly controlled diabetes can cause fluid leakage into the macula (the central part of the retina responsible for detailed vision)

Many of these drugs feature novel mechanisms of action or routes of administration and this increased competition may eventually exert downward pressure on pricing

Glucagon like peptide-1 receptor (GLP-1R) is a member of the B family of G protein-coupled receptors

In obesity treatment, especially among patients without prior experience with injectable drugs, there may be greater resistance or hesitation

After screening titles and abstracts, 64 studies were selected for full-text review, and 41 articles were ultimately included in this review, including 12 randomized controlled trials, 16 observational studies, and 13 mechanistic or preclinical studies